CRYOPRESERVED ePBMC®

NK-Activity Characterized PBMC

PBMC from normal, healthy donors were screened for NK activity using the CTL TVA™ Platform, and the percentage of killing is shown for K562 tumor cells. PBMC samples were incubated at different ratios of Effector Cells (PBMC containing NK cells) to Target Cells (K562 tumor cells labeled with fluorescent TVA™ Dye.) Following a four hour incubation period, the remaining labeled Target Cells were counted using the ImmunoSpot® TVA™ Platform, and the percentage of killing at each ratio was determined. The resulting killing curves are shown below.

More about the CTL NK-TVA™ Platform


005 NK-LP 123

Enlarge / Inquire

006 NK LP 133

Enlarge / Inquire

007 NK LP 108

Enlarge / Inquire

008 NK LP 135

Enlarge / Inquire

009 NK LP 180

Enlarge / Inquire

010 NK LP 140

Enlarge / Inquire

011 NK LP 184

Enlarge / Inquire

012 NK LP 132

Enlarge / Inquire

014 NK LP 188

Enlarge / Inquire

017 NK LP 113

Enlarge / Inquire

018 NK LP 191

Enlarge / Inquire

022 NK LP 20

Enlarge / Inquire

023 NK LP 98

Enlarge / Inquire

025 NK LP 162

Enlarge / Inquire

029 NK LP 154

Enlarge / Inquire

030 NK LP 88

Enlarge / Inquire

036 NK LP 65

Enlarge / Inquire

041 NK LP 56

Enlarge / Inquire

044 NK LP 82

Enlarge / Inquire

045 NK LP 105

Enlarge / Inquire

046 NK LP 149

Enlarge / Inquire

047 NK LP 142

Enlarge / Inquire

049 NK LP 158

Enlarge / Inquire

051 NK LP 181

Enlarge / Inquire

053 NK LP 116

Enlarge / Inquire

056 NK LP 78

Enlarge / Inquire

057 NK LP 161

Enlarge / Inquire

059 NK LP 119

Enlarge / Inquire

060 NK LP 96

Enlarge / Inquire

065 NK LP 73

Enlarge / Inquire

066 NK LP 77

Enlarge / Inquire

068 NK LP 194

Enlarge / Inquire

070 NK LP 99

Enlarge / Inquire

073 NK LP 11

Enlarge / Inquire

077 NK LP 126

Enlarge / Inquire

082 NK LP 121

Enlarge / Inquire

091 NK LP 50

Enlarge / Inquire

095 NK LP 7

Enlarge / Inquire

097 NK LP 157

Enlarge / Inquire

099 NK LP 182

Enlarge / Inquire

101 NK LP 70

Enlarge / Inquire

104 NK LP 92

Enlarge / Inquire

106 NK LP 141

Enlarge / Inquire

111 NK LP 115

Enlarge / Inquire

115 NK LP 81

Enlarge / Inquire

119 NK LP 147

Enlarge / Inquire

120 NK LP 151

Enlarge / Inquire

121 NK LP 316

Enlarge / Inquire

122 NK LP 317

Enlarge / Inquire

123 NK LP 322

Enlarge / Inquire

124 NK LP 327

Enlarge / Inquire

125 NK LP 328

Enlarge / Inquire

126 NK LP 331

Enlarge / Inquire

127 NK LP 333

Enlarge / Inquire

128 NK LP 334

Enlarge / Inquire

129 NK LP 337

Enlarge / Inquire

130 NK LP 339

Enlarge / Inquire


CTL Europe GmbH 
Hans-Boeckler-Str. 19-29 | 53225 Bonn, Germany
+49 228 85 44 78-0 | +49 228 85 44 78-22 Fax                     
Privacy Policy | Imprint | Sitemap
ctl-europe@immunospot.eu | www.immunospot.eu

© 2017 CTL Europe GmbH